» Articles » PMID: 39385645

A Randomized, Single-Center, Double-Blind, Controlled Case Study Evaluating Procedure Pairing of a Neurocosmetic Postprocedure Cream With Radiofrequency Microneedling for Facial Rejuvenation

Overview
Specialty Dermatology
Date 2024 Oct 10
PMID 39385645
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radiofrequency (RF) microneedling produces patient discomfort which deters patients from completing the recommended treatment series.

Objective: The primary objective was to determine the tolerability, safety, and efficacy of a neurocosmetic postprocedure cream post-RF microneedling in reducing patient discomfort and enhancing recovery across the length of the study and, secondarily, to evaluate against a leading comparator. The third objective was to evaluate the efficacy of the neurocosmetic on self-perceived improvement and objective grading.

Materials And Methods: An Institutional Review Board (IRB) approved, fourteen-day, randomized, single-center, double-blind, controlled clinical case study was conducted with 11 healthy female subjects, 6 randomized to the neurocosmetic and 5 to the comparator cell. Following a 7-day washout period, subjects received RF microneedling (face and neck) and applied the postprocedure cream twice daily for 7 days. Objective and subjective tolerability, self-assessments, and clinical photography were performed immediately postprocedure, 24 h, three and seven days following the procedure.

Results: The neurocosmetic was tolerable and safe. Erythema and stinging immediately decreased postprocedure, postneurocosmetic application. After 24 h, 83% favorably agreed the neurocosmetic "reduced irritation on the skin post-procedure," and after 7 days, 100% favorably agreed "experience with the product was positive and I would be interested in returning for a second treatment." The neurocosmetic reduced skin tone redness in the face and neck faster and to a greater degree when measured against a comparator.

Conclusion: The neurocosmetic postprocedure cream improved patient discomfort and enhanced recovery when used immediately post-RF microneedling and after 7 days.

Irb Protocol Number: Pro00064211.

References
1.
Gowda A, Healey B, Ezaldein H, Merati M . A Systematic Review Examining the Potential Adverse Effects of Microneedling. J Clin Aesthet Dermatol. 2021; 14(1):45-54. PMC: 7869810. View

2.
Kueper T, Krohn M, Haustedt L, Hatt H, Schmaus G, Vielhaber G . Inhibition of TRPV1 for the treatment of sensitive skin. Exp Dermatol. 2010; 19(11):980-6. DOI: 10.1111/j.1600-0625.2010.01122.x. View

3.
Szallasi A, Cortright D, Blum C, Eid S . The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov. 2007; 6(5):357-72. DOI: 10.1038/nrd2280. View

4.
Bloom B, Emer J, Goldberg D . Assessment of safety and efficacy of a bipolar fractionated radiofrequency device in the treatment of photodamaged skin. J Cosmet Laser Ther. 2012; 14(5):208-11. DOI: 10.3109/14764172.2012.724534. View

5.
Vechtomova Y, Telegina T, Buglak A, Kritsky M . UV Radiation in DNA Damage and Repair Involving DNA-Photolyases and Cryptochromes. Biomedicines. 2021; 9(11). PMC: 8615538. DOI: 10.3390/biomedicines9111564. View